They have good software. Last year, they lost $.16, this year they'll earn $ .04 and next year $ .08. Every quarter last year, they lowered guidance. Too expensive.

An interesting company. Prefers TIR Systems. Would like to see their backlog grow.

Probably fully valued.

Is interested in small caps that become large, not large caps that become small. Not enough earnings.

Likes the company, but has always been a little bit ahead of what he wants to pay for it. Good earnings. Fairly priced. Still watching.

Not sure where their backlog will be coming from. Probably fairly valued.

Has very strong visibility. Earnings that exceeded expectations last quarter. Have raised guidance for the last five quarters. Dividends.

Has very good visibility into revenues. Planning on moving to the TSX this year. A good backlog of orders.

Have FDA clearance. Revenue is growing. Attractive technology. Reached his price target, so sold.

Not a buyer at this price.